Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
  1. 4 Grant or award Director acquired 12,500 shares (grant or award)
  2. 4 Grant or award Director acquired 17,500 shares (grant or award)
  3. 4 Exercise or conversion Exec VP of Tech Operations acquired 18,029 shares (option exercise)
  4. 4 Open-market buy Director bought 20,000 shares at $1.18 ($23,500)
  5. 4 Open-market buy Director bought 100,000 shares at $1.24 ($124,410)
  6. 4 Open-market buy Director bought 50,000 shares at $1.47 ($73,300)
  7. 4 Exercise or conversion EVP, Head of Clinical Ops. acquired 40,000 shares (option exercise)
  8. 4/A Grant or award Director acquired 22,000 shares (grant or award)
  9. 4/A Derivatives Options or other derivatives
  10. 4/A Grant or award Director acquired 10,000 shares (grant or award)
  11. 4/A Grant or award Director acquired 12,500 shares (grant or award)
  12. 4/A Grant or award Director acquired 10,000 shares (grant or award)
  13. 4/A Shares withheld for taxes Director gave up 468,750 shares (to pay taxes)
  14. 4/A Grant or award Director acquired 14,000 shares (grant or award)
  15. 4/A Grant or award Director acquired 16,000 shares (grant or award)
  16. 4 Open-market buy Exec VP of Tech Operations bought 250,000 shares at $1.45 ($363,150)
  17. 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $1.22 ($30,495)
  18. 4 Open-market buy Chief Financial Officer bought 25,000 shares at $1.17 ($29,213)
  19. 4 Open-market buy Director bought 50,000 shares at $1.30 ($64,795)
  20. 4/A Grant or award Director acquired 10,000 shares (grant or award)

Page 12 of 26 · 515 filings